DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Q4 2013 Regeneron Pharmaceutica Earnings Conference call (Webcast)

Will Regeneron (REGN) Disappoint in Q4? - Analyst Blog

Why Regeneron Pharmaceuticals Has A Bright Future Ahead

Pre-Market Earnings Report for February 11, 2014 : CVS, S, REGN, RAI, MMC, OMC, PCG, HCP, IR, ICE,

Pre-Market Earnings Report for February 11, 2014 : CVS, S, REGN, RAI, MMC, OMC, PCG, HCP, IR, ICE, ETR, HSIC

Healthcare Stocks Still Adding to Late Gains; Regeneron Pharma Rises After Positive 2-Year Data for

Healthcare Stocks Still Adding to Late Gains; Regeneron Pharma Rises After Positive 2-Year Data for Eyesight Drug

Jim Cramer's 6 Stocks in 60 Seconds: AXP STJ MDP FUEL FWM REGN

Yelp, Regeneron, Dick’s Sporting Goods rise

Is There Investment Upside In The Future Of Treating Diabetes?

UPDATE: Regeneron Reports Two-Year Results from Phase 3 VISTA Trail of Eylea, Says Showed Sustained

UPDATE: Regeneron Reports Two-Year Results from Phase 3 VISTA Trail of Eylea, Says Showed Sustained Improvement in Vision

3 Key Takeaways From Sanofi's Fourth-Quarter Earnings

Let’s discuss 3 key takeaways from Sanofi’s fourth-quarter earnings, and how competitors like Shire and Eli Lilly, and partners like Regeneron, could affect its growth in 2014.